Athanor Capital’s Ascendis Pharma A/S ASND Stock Holding History

Athanor Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,779	Closed	-$1.26M	–	462
2021 Q1	$1.26M	Sell	9,779 -14,874	-60%	-$2.26M	0.03%	292
2020 Q4	$4.11M	Buy	24,653 +8,994	+57%	+$1.49M	0.09%	141
2020 Q3	$2.42M	Sell	15,659 -11,350	-42%	-$1.63M	0.09%	117
2020 Q2	$4M	Buy	27,009 +23,231	+615%	+$3.19M	0.2%	79
2020 Q1	$425K	Sell	3,778 -20,505	-84%	-$2.66M	0.03%	136
2019 Q4	$3.38M	Buy	24,283 +7,745	+47%	+$860K	0.15%	89
2019 Q3	$1.59M	Buy	16,538 +8,338	+102%	+$930K	0.1%	86
2019 Q2	$944K	Buy	8,200 +6,300	+332%	+$754K	0.12%	78
2019 Q1	$224K	Buy	+1,900	New	+$166K	0.04%	64

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Athanor Capital's ASND Position: Q2 2021 in Review

Athanor Capital sold out of Ascendis Pharma A/S (ASND) in Q2 2021, closing a stake of 9,779 shares — an estimated $1.26M sold.

Athanor Capital first reported a position in ASND in Q1 2019 and held it in 9 quarters. The position peaked at $4.11M in Q4 2020. 171 funds tracked by Wall St. Rank hold ASND as of Q2 2021.

Athanor Capital reported no remaining Ascendis Pharma A/S position as of Q2 2021 after selling out during the quarter.
Athanor Capital sold 9,779 Ascendis Pharma A/S shares in Q2 2021, an estimated $1.26M.
Athanor Capital first reported a position in Ascendis Pharma A/S in Q1 2019 and held it in 9 quarters.
Athanor Capital's Ascendis Pharma A/S position peaked at $4.11M in Q4 2020.
171 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.